Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,148
datasets available to search
ShareScore release 0.9.0
Dataset results
2,148 results for “HER2”
T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer
ClinicalTrials.gov study NCT03530696. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity
ClinicalTrials.gov study NCT05036252. IPD Sharing: YES. Countries: 1. Publications: 0.
Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer
ClinicalTrials.gov study NCT02712723. IPD Sharing: NO. Countries: 1. Publications: 0.
An Observational Study of the Mean Duration of Trastuzumab (Herceptin) Treatment in Participants With Early or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
ClinicalTrials.gov study NCT01187381. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TAC T-cells for the Treatment of HER2-positive Solid Tumors
ClinicalTrials.gov study NCT04727151. IPD Sharing: NO. Countries: 2. Publications: 0.
Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer
ClinicalTrials.gov study NCT01498588. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Alpelisib (BYL719) in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy in Patients With HER2-positive Advanced Breast Cancer With a PIK3CA Mutation
ClinicalTrials.gov study NCT04208178. IPD Sharing: YES. Countries: 7. Publications: 0.
A Study of Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer Who Have Received Prior Trea
ClinicalTrials.gov study NCT02658734. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine Versus the Combination of Trastuzumab Plus Docetaxel in Patients With HER2-positive Breast Cancer
ClinicalTrials.gov study NCT02144012. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Afatinib and Vinorelbine in Tumours Known to Overexpress EGFR and/or HER2
ClinicalTrials.gov study NCT00906698. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer
ClinicalTrials.gov study NCT06488378. IPD Sharing: YES. Countries: 1. Publications: 0.
Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT01033032. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Subcutaneously Administered Herceptin (Trastuzumab) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer
ClinicalTrials.gov study NCT01928615. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx
ClinicalTrials.gov study NCT02038010. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer
ClinicalTrials.gov study NCT00079326. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HER-Seq: A Blood-based Screening Study to Identify Patients With HER2 Mutations for Enrollment Into Clinical Research Studies of Neratinib
ClinicalTrials.gov study NCT03786107. IPD Sharing: YES. Countries: 7. Publications: 0.
Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast Cancer
ClinicalTrials.gov study NCT02311933. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)
ClinicalTrials.gov study NCT07241793. IPD Sharing: NO. Countries: 1. Publications: 0.
Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
ClinicalTrials.gov study NCT07070466. IPD Sharing: YES. Countries: 1. Publications: 0.
The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast Cancer
ClinicalTrials.gov study NCT03414658. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.